Another translational study of 60 CRC patients revealed that 18p TERRA, in conjunction with CEA, served as a prognostic factor, particularly influencing progression-free survival and, to a lesser extent, OS [12]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.